newsfilter
← Latest News
Business Wire·

Definium Therapeutics, Inc. Announces Proposed Public Offering

Definium Therapeutics, Inc. (NASDAQ:DFTX) (the "Company" or "Definium"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes